Published in Nature on July 07, 1977
Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes. Br J Pharmacol (1983) 1.96
Distinct activities of GABA agonists at synaptic- and extrasynaptic-type GABAA receptors. J Physiol (2010) 1.58
Molecular basis for the high THIP/gaboxadol sensitivity of extrasynaptic GABA(A) receptors. J Neurophysiol (2011) 1.40
Pharmacology of GABA rho 1 and GABA alpha/beta receptors expressed in Xenopus oocytes and COS cells. Br J Pharmacol (1993) 1.09
A unified model of the GABA(A) receptor comprising agonist and benzodiazepine binding sites. PLoS One (2013) 1.02
Carboxylic acid (bio)isosteres in drug design. ChemMedChem (2013) 0.97
Agonist pharmacology of two Drosophila GABA receptor splice variants. Br J Pharmacol (1996) 0.96
GABAB receptor modulation of adenylate cyclase activity in rat brain slices. Br J Pharmacol (1985) 0.90
Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia. Psychopharmacology (Berl) (2010) 0.88
Electrophysiological studies of the GABAA receptor ligand, 4-PIOL, on cultured hippocampal neurones. Br J Pharmacol (1991) 0.86
Stimulation of receptors of gamma-aminobutyric acid modulates the release of cholecystokinin-like immunoreactivity from slices of rat neostriatum. Br J Pharmacol (1986) 0.86
Fluorinated conformationally restricted gamma-aminobutyric acid aminotransferase inhibitors. J Med Chem (2006) 0.83
The excitation and depression of spinal neurones by ibotenic acid. J Physiol (1979) 0.82
Effects of GABA(A) receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions. Br J Pharmacol (2001) 0.81
Extracellular alkalinization evoked by GABA and its relationship to activity-dependent pH shifts in turtle cerebellum. J Physiol (1991) 0.81
An arylaminopyridazine derivative of gamma-aminobutyric acid (GABA) is a selective and competitive antagonist at the GABAA receptor site. Proc Natl Acad Sci U S A (1985) 0.81
Lack of generalisation between the GABAA receptor agonist, gaboxadol, and allosteric modulators of the benzodiazepine binding site in the rat drug discrimination procedure. Psychopharmacology (Berl) (2007) 0.79
A reinforcing circuit action of extrasynaptic GABAA receptor modulators on cerebellar granule cell inhibition. PLoS One (2013) 0.78
The action of GABA receptor agonists and antagonists on muscle membrane conductance in Schistocerca gregaria. Br J Pharmacol (1988) 0.76
Selective antinociceptive effects of tizanidine (DS 103-282), a centrally acting muscle relaxant, on dorsal horn neurones in the feline spinal cord. Br J Pharmacol (1984) 0.75
Entanglement between thermoregulation and nociception in the rat: the case of morphine. J Neurophysiol (2016) 0.75
Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes. 1983. Br J Pharmacol (1997) 0.75
Increase in the Bmax of gamma-aminobutyric acid-A recognition sites in brain regions of mice receiving diazepam. Proc Natl Acad Sci U S A (1984) 0.75
gamma-Aminobutyric acid receptors visualized in spinal cord cultures by [3H]muscimol autoradiography. Proc Natl Acad Sci U S A (1978) 0.75
Amino acid transmitters in the mammalian central nervous system. Ergeb Physiol (1974) 5.99
Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science (1988) 4.00
The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol (1983) 3.69
GABA, bicuculline and central inhibition. Nature (1970) 3.55
Bicuculline, an antagonist of GABA and synaptic inhibition in the spinal cord of the cat. Brain Res (1971) 3.52
The structure of bovine rhodopsin. Biophys Struct Mech (1983) 3.33
The hyperpolarization of spinal motoneurones by glycine and related amino acids. Exp Brain Res (1968) 3.00
A pharmacological study of the depression of spinal neurones by glycine and related amino acids. Exp Brain Res (1968) 2.95
The pharmacology of amino acids related to gamma-aminobutyric acid. Pharmacol Rev (1965) 2.81
A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature (1997) 2.74
Melasma of the arms associated with hormone replacement therapy. Br J Dermatol (1998) 2.45
Kainate receptors are involved in synaptic plasticity. Nature (1999) 2.43
The specificity of strychnine as a glycine antagonist in the mammalian spinal cord. Exp Brain Res (1971) 2.41
Antagonism between bicuculline and GABA in the cat brain. Brain Res (1971) 2.29
Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol Sci (1990) 2.21
Central synaptic transmission--microelectrophoretic studies. Annu Rev Pharmacol (1969) 2.17
The structural specificity of the high affinity uptake of L-glutamate and L-aspartate by rat brain slices. J Neurochem (1972) 2.15
Pharmacological studies on feline Betz cells. J Physiol (1966) 2.11
Spinal interneurone excitation by conformationally restricted analogues of L-glutamic acid. Nature (1974) 2.09
GABA uptake in rat central nervous system: comparison of uptake in slices and homogenates and the effects of some inhibitors. J Neurochem (1971) 2.00
The acetylcholine receptors of Renshaw cells. Exp Brain Res (1966) 1.87
An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine? Nature (1985) 1.81
The synaptic excitation of Renshaw cells. Exp Brain Res (1966) 1.74
Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds. J Neurochem (1975) 1.67
Phaclofen: a peripheral and central baclofen antagonist. Brain Res (1987) 1.66
Tetanus toxin and spinal inhibition. Brain Res (1968) 1.59
Ligands for glutamate receptors: design and therapeutic prospects. J Med Chem (2000) 1.58
Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat. Brain Res (1987) 1.58
Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations. Mol Pharmacol (1994) 1.57
Excitation of mammalian central neurones by acidic amino acids. Brain Res (1972) 1.52
GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology. J Med Chem (2000) 1.51
The excitation of Renshaw cells by cholinomimetics. Exp Brain Res (1966) 1.48
The antagonism of amino acid-induced excitation of spinal neurones in the cat. Brain Res (1979) 1.47
The effect of bicuculline upon synaptic inhibition in the cerebral and cerebellar corticles of the cat. Brain Res (1971) 1.47
The intraspinal distribution of some depressant amino acids. J Neurochem (1968) 1.46
Proceedings: Rhythmical field potentials induced in the inferior olive complex by iontophoretically applied harmaline and other unrelated alkaloids. Br J Pharmacol (1973) 1.45
2-Hydroxy-saclofen: an improved antagonist at central and peripheral GABAB receptors. Neurosci Lett (1988) 1.44
Neuropharmacology of AMPA and kainate receptors. Neuropharmacology (1999) 1.43
Bicuculline methochloride as a GABA antagonist. Nat New Biol (1972) 1.40
Action of the neurotoxin kainic acid on high affinity uptake of L-glutamic acid in rat brain slices. J Neurochem (1979) 1.39
New class of glutamate agonist structurally related to ibotenic acid. Nature (1980) 1.38
High affinity uptake of transmitters: studies on the uptake of L-aspartate, GABA, L-glutamate and glycine in cat spinal cord. J Neurochem (1973) 1.37
Epileptiform activity induced by alkalosis in rat neocortical slices: block by antagonists of N-methyl-D-aspartate. Neurosci Lett (1987) 1.36
Structure and biological activity of a series of conformationally restricted analogues of GABA. J Neurochem (1975) 1.32
Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles. Neuropharmacology (1996) 1.32
Tetanus toxin and the synaptic release of GABA. Brain Res (1973) 1.31
The inactivation of extracellularly administered amino acids in the feline spinal cord. Exp Brain Res (1970) 1.31
Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology (1993) 1.31
Differences in agonist/antagonist binding affinity and receptor transduction using recombinant human gamma-aminobutyric acid type A receptors. Mol Pharmacol (1997) 1.30
Inhibition of the uptake of GABA and related amino acids in rat brain slices by the optical isomers of nipecotic acid. J Neurochem (1976) 1.28
A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP. Neuron (2001) 1.27
Selective effects of (-)-baclofen on spinal synaptic transmission in the cat. Exp Brain Res (1981) 1.26
The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity. Neuropharmacology (1998) 1.25
Glycine uptake in rat central nervous system slices and homogenates: evidence for different uptake systems in spinal cord and cerebral cortex. J Neurochem (1971) 1.24
Acetylcholine sensitivity of cerebellar neurones in the cat. J Physiol (1966) 1.24
Bicuculline and central GABA receptors. Nature (1970) 1.23
gamma-Aminobutyric acid agonists: an in vitro comparison between depression of spinal synaptic activity and depolarization of spinal root fibres in the rat. Br J Pharmacol (1980) 1.23
The 'ABC' of GABA receptors: a brief review. Clin Exp Pharmacol Physiol (1999) 1.23
Baclofen: stereoselective inhibition of excitant amino acid release. J Pharm Pharmacol (1980) 1.22
Effects of ketamine and three other anaesthetics on spinal reflexes and inhibitions in the cat. Br J Anaesth (1984) 1.21
Neuropharmacology of amino acid inhibitory transmitters. Annu Rev Pharmacol Toxicol (1978) 1.20
The in vivo inactivation of GABA and other inhibitory amino acids in the cat nervous system. Exp Brain Res (1976) 1.20
DHPG-induced LTD in area CA1 of juvenile rat hippocampus; characterisation and sensitivity to novel mGlu receptor antagonists. Neuropharmacology (1999) 1.20
Comparison of sigma- and kappa-opiate receptor ligands as excitatory amino acid antagonists. Br J Pharmacol (1984) 1.20
Convulsive action of penicillin. Brain Res (1972) 1.19
The pharmacology of the inhibition of dorsal horn neurones by impulses in myelinated cutaneous afferents in the cat. Exp Brain Res (1975) 1.19
Pharmacological studies upon spinal presynaptic fibres. Exp Brain Res (1966) 1.18
The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain. J Biol Chem (1999) 1.18
Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett (1995) 1.17
Central effects of beta-(para-chlorophenyl)-gamma-aminobutyric acid. Brain Res (1974) 1.17
Uptake and release of D- and L-aspartate by rat brain slices. J Neurochem (1976) 1.17
Chalk eating in middle Georgia: a culture-bound syndrome of pica? South Med J (1999) 1.17
Inhibition of spinal neurons by glycine. Nature (1967) 1.17
Central actions of benzodiazepines. Brain Res (1976) 1.16
Ketamine acts as a non-competitive N-methyl-D-aspartate antagonist on frog spinal cord in vitro. Neuropharmacology (1985) 1.14